Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of csgA Prevalence, Gene Expression and Week-to-Week Variability in Participants With Parkinson's Disease and a History of Gastrointestinal Dysfunction

NCT07175922 is registered in ClinicalTrials.gov with Vertero Therapeutics as lead sponsor.

NCT NCT07175922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07175922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of csgA Prevalence, Gene Expression and Week-to-Week Variability in Participants With Parkinson's Disease and a History of Gastrointestinal Dysfunction
Lead sponsor
Vertero Therapeutics
Phase
Observational
Overall status
Recruiting
Start date
September 25, 2025
Completion date
November 30, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinsons disease (pd)